Open house discount agreements Infliximab
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Infliximab, ATC L04AB02
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
No estimated value or framework maximum is provided. The actual revenue opportunity is unknown and depends on prescript...
If a nationwide or regional exclusive discount contract for Infliximab is concluded, open-house agreements terminate au...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Supply of Infliximab (ATC L04AB02) pharmaceutical products to AOK Bayern under discount agreements.
- Non-exclusive framework agreements; all eligible pharmaceutical companies can participate.
Show full summary
This is an open-house model for non-exclusive discount agreements on the active substance Infliximab (ATC L04AB02) with AOK Bayern. It is not a formal procurement procedure but a voluntary admission system under § 130a Abs. 8 SGB V. All interested pharmaceutical companies that meet the eligibility criteria can conclude identical, non-negotiable discount agreements. The earliest contract start is 01.11.2024, and all contracts end on 31.10.2026. No estimated value is provided. The procedure is classified as an open procedure in the notice but explicitly stated to be outside procurement law.
Risks
No estimated value or framework maximum is provided. The actual revenue opportunity is unknown and depends on prescript...
If a nationwide or regional exclusive discount contract for Infliximab is concluded, open-house agreements terminate au...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible as potential contracting partners.
Administrative
- Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submission of the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house discount agreements Infliximab
Non-exclusive discount agreements for Infliximab (ATC L04AB02) with AOK Bayern. All eligible pharmaceutical companies can join under identical terms. No selection or competition.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Infliximab, ATC L04AB02
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Sep 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 558403-2024
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
No estimated value or framework maximum is provided. The actual revenue opportunity is unknown and depends on prescript...
If a nationwide or regional exclusive discount contract for Infliximab is concluded, open-house agreements terminate au...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications